Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study
United European Gastroenterology Journal · 2026
DOI: 10.1002/ueg2.70169 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift United European Gastroenterology Journal, 2026. Verfasst von Antoni Castells und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hospital Clínic of Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestiva…. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms, Early Detection of Cancer, Mass Screening. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación Científica Asociación Española Contra el Cáncer, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) screening is effective and cost‐effective in average‐risk individuals. The COLONPREV study recently showed that individuals invited to a faecal immunochemical test (FIT) were more likely to participate in screening than those invited to colonoscopy, and that FIT‐based screening was non‐inferior to colonoscopy with respect to CRC‐related mortality and CRC incidence.
Objective
To assess whether the outcomes of colonoscopy‐ and FIT‐based screening differ according to sex and age in the invited population.
Methods
Presumptively healthy men and women aged 50–69 years were randomised to either a one‐time screening colonoscopy or biennial FIT. In this analysis, we report participation and crossover rates, CRC‐related mortality, CRC incidence, all‐cause mortality, and diagnostic yield for both screening strategies, stratified by sex and by age group (50–59 and 60–69 years).
Results
The eligible population consisted of 26,332 individuals assigned to colonoscopy and 26,719 assigned to FIT. As expected, participation and crossover rates were higher in women than in men and in older individuals compared with younger individuals. Participation was also consistently higher in those invited to FIT screening than in those assigned to colonoscopy across both sexes and age groups. The observed reductions in CRC‐related mortality and CRC incidence, which were consistent across both screening strategies, were independent of sex or age. However, CRC‐related mortality, all‐cause mortality, and CRC incidence remained higher in men and older participants than in women and younger participants. Colonoscopy screening showed a higher diagnostic yield of premalignant precursor lesions across all demographic subgroups.
Conclusion
Participation and reductions in CRC‐related mortality and incidence were consistent across sex and age groups for both FIT‐ and colonoscopy‐based screening strategies. The higher baseline risk observed in men could not be fully mitigated by screening. Trial Registration ClinicalTrials.gov: NCT00906997
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, Hospital Clínic of Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Barcelona, Spain.
- Department of Gastroenterology, Hospital Universitario de Canarias, Instituto Universitario de Tecnologías Biomédicas, Universidad de La Laguna, Tenerife, Spain.
- Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
- Department of Hepatology and Gastroenterology, Biogipuzkoa Health Research Institute - Donostia University Hospital, Universidad del País Vasco (UPV/EHU), CIBERehd, San Sebastián, Spain.
- General Directorate of Public Health, Regional Ministry of Health, Valencia, Spain.
- Department of Gastroenterology, Hospital Universitario de Ourense, Grupo de Investigación en Oncología Digestiva-Ourense, CIBERehd, Ourense, Spain.
ORCID-Profile: Miquel Serra-Burriel, Montserrat Andreu
Förderung
- Fundación Científica Asociación Española Contra el Cáncer
- Instituto de Salud Carlos III
Zitieren
APA
Castells, A., Quintero, E., Serra-Burriel, M., Bujanda, L., Castán-Cameo, S., Cubiella, J., Díaz-Tasende, J., Lanas, Á., Ono, A., Coll-Vinent, B., Frías-Arrocha, E., Hernández, C., Jover, R., Andreu, M., Carballo, F., Morillas, J. D., Salas, D., & COLONPREV study investigators (2026). Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70169
Vancouver
Castells A, Quintero E, Serra-Burriel M, Bujanda L, Castán-Cameo S, Cubiella J, et al. Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study. United European Gastroenterology Journal. 2026. doi:10.1002/ueg2.70169
BibTeX
@article{Castells2026,
author = {Castells, Antoni and Quintero, Enrique and Serra-Burriel, Miquel and Bujanda, Luis and Castán-Cameo, Susana and Cubiella, Joaquín and Díaz-Tasende, José and Lanas, Ángel and Ono, Akiko and Coll-Vinent, Blanca and Frías-Arrocha, Eladio and Hernández, Cristina and Jover, Rodrigo and Andreu, Montserrat and Carballo, Fernando and Morillas, Juan Diego and Salas, Dolores and COLONPREV study investigators, COLONPREV study investigators},
title = {Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study},
journal = {United European Gastroenterology Journal},
year = {2026},
doi = {10.1002/ueg2.70169}
}
EUVIMED